Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
03 Jul 2017 FDA Approves Betrixaban for the Prophylaxis of VTE in Adult Patients Palliative and supportive care
01 Jul 2017 World GI 2017 Press Release: Right-sided Colorectal Tumours: An Internal Radiation Advantage Gastrointestinal cancers
30 Jun 2017 FDA Approves Rituximab Plus Hyaluronidase Combination for Treatment of FL, DLBCL and CLL Haematologic malignancies - Anticancer agents & Biologic therapy
30 Jun 2017 World GI 2017 Press Release: Zoning in on Specifics of Mediterranean Diet for Colorectal Health Gastrointestinal cancers
28 Jun 2017 EMA Recommends Extensions of Therapeutic Indications for Regorafenib Gastrointestinal cancers - Anticancer agents & Biologic therapy
27 Jun 2017 EMA Recommends Granting a Marketing Authorisation for Tivozanib Hydrochloride Monohydrate Genitourinary cancers - Anticancer agents & Biologic therapy
26 Jun 2017 EMA Recommends Granting a Marketing Authorisation for Ribociclib Breast cancer - Anticancer agents & Biologic therapy
23 Jun 2017 FDA Grants Regular Approval to Dabrafenib and Trametinib Combination for Metastatic NSCLC with BRAF V600E Mutation Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
22 Jun 2017 Efficacy Results From I-SPY 2 Trial Show Improved Outcomes with Combination Pembrolizumab Plus Standard Neoadjuvant Therapy for High-Risk Breast Cancer Breast cancer - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
21 Jun 2017 Entry into Application of EU Clinical Trial Regulation Postponed to 2019 Bioethics, legal and economic issues
20 Jun 2017 Recommendations from the AACR Childhood Cancer Predisposition Workshop Epidemiology/Etiology/Cancer Prevention - Cancer in Special Situations
19 Jun 2017 Catalyzing Integration of Genomic and Clinical Datasets Across Multiple Cancer Institutions Worldwide Translational research
16 Jun 2017 NICE Issues Technology Appraisal Guidance for Brentuximab Vedotin in CD30-Positive Hodgkin Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
14 Jun 2017 EMA – PRAC Concludes There Is No Evidence of a Change in Known Risk of Neutropenic Enterocolitis With Docetaxel Anticancer agents & Biologic therapy
13 Jun 2017 FDA Approves Aminolevulinic Acid Hydrochloride as an Optical Imaging Agent Indicated in Patients with Gliomas Diagnosis, Imaging and Staging - Central nervous system malignancies